Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud

More shots have been fired in the patent proxy war between CAR-T giants Gilead Sciences and Bristol Myers Squibb as Gilead moved to parry a recent BMS petition to the United States’ High Court.